Drug Information

Drug General Information
Drug ID
D08MOG
Former ID
DNC010100
Drug Name
4-(Pent-3-ylamino)-1-naphthol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530623]
Formula
C15H19NO
Canonical SMILES
CCC(CC)NC1=CC=C(C2=CC=CC=C21)O
InChI
1S/C15H19NO/c1-3-11(4-2)16-14-9-10-15(17)13-8-6-5-7-12(13)14/h5-11,16-17H,3-4H2,1-2H3
InChIKey
LZQSUKJAJXHQLF-UHFFFAOYSA-N
PubChem Compound ID
45487171
Target and Pathway
Target(s) Indoleamine 2,3-dioxygenase Target Info Inhibitor [530623]
BioCyc Pathway Superpathway of tryptophan utilization
Tryptophan degradation
L-kynurenine degradation
Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
NAD de novo biosynthesis
KEGG Pathway Tryptophan metabolism
Metabolic pathways
African trypanosomiasis
NetPath Pathway TSLP Signaling Pathway
IL5 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
PathWhiz Pathway Tryptophan Metabolism
Reactome Tryptophan catabolism
WikiPathways Tryptophan metabolism
Metabolism of amino acids and derivatives
References
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.